Copyright Reports & Markets. All rights reserved.

Global and China Antidiabetics Drug Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Antidiabetics Drug Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Antidiabetics Drug Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Antidiabetics Drug Market Size Growth Rate by Type
    • 1.4.2 Metformin (Biguanides)
    • 1.4.3 Insulin Sensitization Agent (TZD Use)
    • 1.4.4 Sulfonated Ideal Urea Class
    • 1.4.5 Meglitinides
    • 1.4.6 Alpha Glucosidase Inhibitors
  • 1.5 Market by Application
    • 1.5.1 Global Antidiabetics Drug Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Household
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Antidiabetics Drug Market Size, Estimates and Forecasts
    • 2.1.1 Global Antidiabetics Drug Revenue 2015-2026
    • 2.1.2 Global Antidiabetics Drug Sales 2015-2026
  • 2.2 Global Antidiabetics Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Antidiabetics Drug Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Antidiabetics Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Antidiabetics Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Antidiabetics Drug Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Antidiabetics Drug Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Antidiabetics Drug Revenue Forecast by Region (2021-2026)

3 Global Antidiabetics Drug Competitor Landscape by Players

  • 3.1 Global Top Antidiabetics Drug Sales by Manufacturers
    • 3.1.1 Global Antidiabetics Drug Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Antidiabetics Drug Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Antidiabetics Drug Manufacturers by Revenue
    • 3.2.1 Global Antidiabetics Drug Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Antidiabetics Drug Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Antidiabetics Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Antidiabetics Drug Revenue in 2019
    • 3.2.5 Global Antidiabetics Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Antidiabetics Drug Price by Manufacturers
  • 3.4 Global Antidiabetics Drug Manufacturing Base Distribution, Product Types
    • 3.4.1 Antidiabetics Drug Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Antidiabetics Drug Product Type
    • 3.4.3 Date of International Manufacturers Enter into Antidiabetics Drug Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Antidiabetics Drug Market Size by Type (2015-2020)
    • 4.1.1 Global Antidiabetics Drug Sales by Type (2015-2020)
    • 4.1.2 Global Antidiabetics Drug Revenue by Type (2015-2020)
    • 4.1.3 Antidiabetics Drug Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Antidiabetics Drug Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Antidiabetics Drug Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Antidiabetics Drug Revenue Forecast by Type (2021-2026)
    • 4.2.3 Antidiabetics Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Antidiabetics Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Antidiabetics Drug Market Size by Application (2015-2020)
    • 5.1.1 Global Antidiabetics Drug Sales by Application (2015-2020)
    • 5.1.2 Global Antidiabetics Drug Revenue by Application (2015-2020)
    • 5.1.3 Antidiabetics Drug Price by Application (2015-2020)
  • 5.2 Antidiabetics Drug Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Antidiabetics Drug Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Antidiabetics Drug Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Antidiabetics Drug Price Forecast by Application (2021-2026)

6 China by Players, Type and Application

  • 6.1 China Antidiabetics Drug Market Size YoY Growth 2015-2026
    • 6.1.1 China Antidiabetics Drug Sales YoY Growth 2015-2026
    • 6.1.2 China Antidiabetics Drug Revenue YoY Growth 2015-2026
    • 6.1.3 China Antidiabetics Drug Market Share in Global Market 2015-2026
  • 6.2 China Antidiabetics Drug Market Size by Players (International and Local Players)
    • 6.2.1 China Top Antidiabetics Drug Players by Sales (2015-2020)
    • 6.2.2 China Top Antidiabetics Drug Players by Revenue (2015-2020)
  • 6.3 China Antidiabetics Drug Historic Market Review by Type (2015-2020)
    • 6.3.1 China Antidiabetics Drug Sales Market Share by Type (2015-2020)
    • 6.3.2 China Antidiabetics Drug Revenue Market Share by Type (2015-2020)
    • 6.3.3 China Antidiabetics Drug Price by Type (2015-2020)
  • 6.4 China Antidiabetics Drug Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 China Antidiabetics Drug Sales Forecast by Type (2021-2026)
    • 6.4.2 China Antidiabetics Drug Revenue Forecast by Type (2021-2026)
    • 6.4.3 China Antidiabetics Drug Price Forecast by Type (2021-2026)
  • 6.5 China Antidiabetics Drug Historic Market Review by Application (2015-2020)
    • 6.5.1 China Antidiabetics Drug Sales Market Share by Application (2015-2020)
    • 6.5.2 China Antidiabetics Drug Revenue Market Share by Application (2015-2020)
    • 6.5.3 China Antidiabetics Drug Price by Application (2015-2020)
  • 6.6 China Antidiabetics Drug Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 China Antidiabetics Drug Sales Forecast by Application (2021-2026)
    • 6.6.2 China Antidiabetics Drug Revenue Forecast by Application (2021-2026)
    • 6.6.3 China Antidiabetics Drug Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Antidiabetics Drug Market Size YoY Growth 2015-2026
  • 7.2 North America Antidiabetics Drug Market Facts & Figures by Country
    • 7.2.1 North America Antidiabetics Drug Sales by Country (2015-2020)
    • 7.2.2 North America Antidiabetics Drug Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Antidiabetics Drug Market Size YoY Growth 2015-2026
  • 8.2 Europe Antidiabetics Drug Market Facts & Figures by Country
    • 8.2.1 Europe Antidiabetics Drug Sales by Country
    • 8.2.2 Europe Antidiabetics Drug Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Antidiabetics Drug Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Antidiabetics Drug Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Antidiabetics Drug Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Antidiabetics Drug Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Antidiabetics Drug Market Size YoY Growth 2015-2026
  • 10.2 Latin America Antidiabetics Drug Market Facts & Figures by Country
    • 10.2.1 Latin America Antidiabetics Drug Sales by Country
    • 10.2.2 Latin America Antidiabetics Drug Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Antidiabetics Drug Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Antidiabetics Drug Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Antidiabetics Drug Sales by Country
    • 11.2.2 Middle East and Africa Antidiabetics Drug Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 AstraZeneca
    • 12.1.1 AstraZeneca Corporation Information
    • 12.1.2 AstraZeneca Description and Business Overview
    • 12.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 AstraZeneca Antidiabetics Drug Products Offered
    • 12.1.5 AstraZeneca Recent Development
  • 12.2 Bayer
    • 12.2.1 Bayer Corporation Information
    • 12.2.2 Bayer Description and Business Overview
    • 12.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Bayer Antidiabetics Drug Products Offered
    • 12.2.5 Bayer Recent Development
  • 12.3 Boehringer Ingelheim
    • 12.3.1 Boehringer Ingelheim Corporation Information
    • 12.3.2 Boehringer Ingelheim Description and Business Overview
    • 12.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Boehringer Ingelheim Antidiabetics Drug Products Offered
    • 12.3.5 Boehringer Ingelheim Recent Development
  • 12.4 Eli-Lilly
    • 12.4.1 Eli-Lilly Corporation Information
    • 12.4.2 Eli-Lilly Description and Business Overview
    • 12.4.3 Eli-Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Eli-Lilly Antidiabetics Drug Products Offered
    • 12.4.5 Eli-Lilly Recent Development
  • 12.5 Johnson & Johnson
    • 12.5.1 Johnson & Johnson Corporation Information
    • 12.5.2 Johnson & Johnson Description and Business Overview
    • 12.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Johnson & Johnson Antidiabetics Drug Products Offered
    • 12.5.5 Johnson & Johnson Recent Development
  • 12.6 Merck
    • 12.6.1 Merck Corporation Information
    • 12.6.2 Merck Description and Business Overview
    • 12.6.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Merck Antidiabetics Drug Products Offered
    • 12.6.5 Merck Recent Development
  • 12.7 Novartis
    • 12.7.1 Novartis Corporation Information
    • 12.7.2 Novartis Description and Business Overview
    • 12.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Novartis Antidiabetics Drug Products Offered
    • 12.7.5 Novartis Recent Development
  • 12.8 Novo Nordisk
    • 12.8.1 Novo Nordisk Corporation Information
    • 12.8.2 Novo Nordisk Description and Business Overview
    • 12.8.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Novo Nordisk Antidiabetics Drug Products Offered
    • 12.8.5 Novo Nordisk Recent Development
  • 12.9 Sanofi
    • 12.9.1 Sanofi Corporation Information
    • 12.9.2 Sanofi Description and Business Overview
    • 12.9.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Sanofi Antidiabetics Drug Products Offered
    • 12.9.5 Sanofi Recent Development
  • 12.11 AstraZeneca
    • 12.11.1 AstraZeneca Corporation Information
    • 12.11.2 AstraZeneca Description and Business Overview
    • 12.11.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 AstraZeneca Antidiabetics Drug Products Offered
    • 12.11.5 AstraZeneca Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Antidiabetics Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Antidiabetics Drug Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Antidiabetics Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Antidiabetics Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Antidiabetics Drug market is segmented into
    Metformin (Biguanides)
    Insulin Sensitization Agent (TZD Use)
    Sulfonated Ideal Urea Class
    Meglitinides
    Alpha Glucosidase Inhibitors

    Segment by Application, the Antidiabetics Drug market is segmented into
    Hospital
    Household

    Regional and Country-level Analysis
    The Antidiabetics Drug market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Antidiabetics Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Antidiabetics Drug Market Share Analysis
    Antidiabetics Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antidiabetics Drug business, the date to enter into the Antidiabetics Drug market, Antidiabetics Drug product introduction, recent developments, etc.
    The major vendors covered:
    AstraZeneca
    Bayer
    Boehringer Ingelheim
    Eli-Lilly
    Johnson & Johnson
    Merck
    Novartis
    Novo Nordisk
    Sanofi

    Buy now